Quantcast

Latest Pharmaceutical drug Stories

2014-09-21 23:01:40

LifeScienceIndustryResearch.com adds “Flovent (Asthma) – Forecast and Market Analysis to 2023” to its store. Obtain sales forecast for Flovent from 2013-2023 in top eight countries (the US, France, Germany, Italy, Spain, the UK, Japan and Australia). Dallas, Texas (PRWEB) September 21, 2014 Originally approved by the Food and Drug Administration (FDA) in 1996, GSK’s Flovent (fluticasone propionate) is a synthetic ICS therapy with potent anti-inflammatory activity. It is used for...

2014-09-21 23:01:02

The expansion of Canadian's access to primary healthcare services will bolster demand for pharmaceuticals. For these reasons, industry research firm IBISWorld has added a report on the Brand Name Pharmaceutical Manufacturing industry to its growing industry report collection. New York, NY (PRWEB) September 21, 2014 Over the past five years, the patent cliff has enabled more generic drugs to inundate the market, thereby cutting into revenue growth for the Brand Name Pharmaceutical...

2014-09-21 23:00:47

LifeScienceIndustryResearch.com adds “Spiriva (Asthma) – Forecast and Market Analysis to 2023” to its store. Detailed information on Spiriva including product description, safety and efficacy profiles as well as a SWOT analysis. Dallas, Texas (PRWEB) September 22, 2014 The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such as short-acting beta-agonists (SABAs), inhaled corticosteroids (ICSs),...

2014-09-21 23:00:17

LifeScienceIndustryResearch.com adds “Pulmicort (Asthma) – Forecast and Market Analysis to 2023” to its store. Detailed information on Pulmicort including product description, safety and efficacy profiles as well as a SWOT analysis. Dallas, Texas (PRWEB) September 22, 2014 AstraZeneca’s Pulmicort is an ICS therapy that was originally launched in 1997, and is used prophylactically for the maintenance treatment of asthma in children and adults. Its active ingredient, budesonide, is...

2014-09-20 23:02:18

LifeScienceIndustryResearch.com adds “Symbicort (Asthma) - Forecast and Market Analysis to 2023” to its store. Report provides Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan and Australia. Dallas, TX (PRWEB) September 20, 2014 New PharmaPoint Drug Evaluation report, “Symbicort (Asthma) – Forecast and Market Analysis to 2023″. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious...

2014-09-19 23:07:14

HelpRx.info, the leading provider of free prescription discounts, now offers discounts on all common high blood pressure medications. New York, NY (PRWEB) September 19, 2014 Script Relief, operator of HelpRx.info, now offers free Rx discounts on all commonly prescribed high blood pressure medications. HelpRx.info is the leading provider of free online drug coupons and has saved its users over $600,000,000 on prescription costs. To further its mission of making prescription medications...

2014-09-19 23:03:52

LifeScienceIndustryResearch.com adds “Singulair (Asthma) – Forecast and Market Analysis to 2023” to its store. Report provides sales forecast for Singulair for the top eight countries from 2013 to 2023. Dallas, Texas (PRWEB) September 19, 2014 Singulair, developed by Merck, is a CysLT1 receptor inhibitor, blocking the physiologic actions of leukotriene D4 (LTD4). LTD4 belongs to the family of Cys-LTs, which are mediators released from a variety of cells, including mast cells and...

2014-09-19 23:03:18

According to a new report from BCC Research, the global market for human antifungal therapeutics is expected to grow to nearly $13.9 billion by 2018, with a five-year compound annual growth rate (CAGR) of 3.2%. The over-the-counter (OTC) segment is growing at a steady 3.8% CAGR. Wellesley, MA (PRWEB) September 19, 2014 BCC Research reveals in its new report, ANTIFUNGAL DRUGS: TECHNOLOGIES AND GLOBAL MARKETS, the global market for human antifungal therapeutics is expected to grow to...

2014-09-19 23:01:43

The Firm is evaluating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the statin medication. New York, NY (PRWEB) September 19, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) that allege the statin medication caused some patients to develop Type 2 diabetes continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports....

2014-09-19 08:26:05

DALLAS, September 19, 2014 /PRNewswire/ -- RnRMarketResearch.com adds asthma drugs market research reports titled "Asthma - Japan Drug Forecast and Market Analysis to 2023", "Asthma - US Drug Forecast and Market Analysis to 2023" and "Asthma - 5EU Drug Forecast and Market Analysis to 2023" to its online library. According to Asthma - 5EU Drug Forecast and Market Analysis to 2023...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related